Cargando…
Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients
Obesity is increasing in patients with type 2 diabetes. A possible reduced association between fructosamine and glycated hemoglobin (HbA1c) in obese individuals has been previously discussed, but this has never been specifically evaluated in type 2 diabetes, and the potential influence of body fat m...
Autores principales: | Vergès, Bruno, Rouland, Alexia, Baillot‐Rudoni, Sabine, Brindisi, Marie‐Claude, Duvillard, Laurence, Simoneau, Isabelle, Legris, Pauline, Petit, Jean‐Michel, Bouillet, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015815/ https://www.ncbi.nlm.nih.gov/pubmed/32767822 http://dx.doi.org/10.1111/jdi.13383 |
Ejemplares similares
-
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
por: Rouland, Alexia, et al.
Publicado: (2021) -
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023) -
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023) -
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022) -
Serum fructosamine a better indicator than glycated hemoglobin for monitoring gestational diabetes mellitus
por: Ayyappan, S., et al.
Publicado: (2015)